Plimoth Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,610
Closed -$227K 176
2026
Q1
$227K Sell
3,610
-125
-3% -$10K 0.05% 169
2025
Q4
$356K Hold
3,735
0.08% 141
2025
Q3
$365K Sell
3,735
-170
-4% -$17.6K 0.08% 139
2025
Q2
$419K Sell
3,905
-75
-2% -$7.59K 0.1% 123
2025
Q1
$402K Buy
3,980
+1,160
+41% +$117K 0.1% 130
2024
Q4
$252K Hold
2,820
0.06% 149
2024
Q3
$236K Buy
+2,820
New +$222K 0.06% 155

Other funds holding BSX

Plimoth Trust's BSX Position: Q2 2026 in Review

Plimoth Trust sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,610 shares — an estimated $227K sold.

Plimoth Trust first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $419K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Plimoth Trust reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Plimoth Trust sold 3,610 Boston Scientific shares in Q2 2026, an estimated $227K.
  • Plimoth Trust first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
  • Plimoth Trust's Boston Scientific position peaked at $419K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Plimoth Trust's 13F filing for Q2 2026, filed 28 Jul 2026.